Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Equity (2016 - 2025)

Utah Medical Products (UTMD) has 15 years of Return on Equity data on record, last reported at 0.21% in Q3 2025.

  • For Q3 2025, Return on Equity rose 18.0% year-over-year to 0.21%; the TTM value through Sep 2025 reached 0.21%, up 18.0%, while the annual FY2024 figure was 0.11%, 2.0% down from the prior year.
  • Return on Equity reached 0.21% in Q3 2025 per UTMD's latest filing, down from 0.22% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.22% in Q4 2024 and bottomed at 0.02% in Q1 2021.
  • Average Return on Equity over 5 years is 0.1%, with a median of 0.04% recorded in 2023.
  • Peak YoY movement for Return on Equity: fell -11bps in 2023, then increased 19bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.14% in 2021, then crashed by -74bps to 0.04% in 2022, then grew by 7bps to 0.04% in 2023, then skyrocketed by 483bps to 0.22% in 2024, then fell by -6bps to 0.21% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.21% in Q3 2025, 0.22% in Q2 2025, and 0.22% in Q1 2025.